A critical breakthrough in cancer research is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial cancer inhibitor protein is frequently inactivated in many types of malignancies, leading https://social4geek.com/story7666656/mini-antibodies-restore-tumor-suppressor-p53-a-promising-pathway-for-cancer-treatment